A research programme by the Access to Medicine Foundation
The foundation

Access to Medicine Foundation

The Foundation stimulates and guides pharmaceutical companies to do more to improve access to medicine. It is an independent non-profit organisation.
Our programmes

Access to Medicine Index

Ranks 20 of the world’s largest pharmaceutical companies based on their efforts to address access to medicine, including in strategy, governance, R&D and pricing. By publicly recognising the best performers, the Index spurs companies to compete to be the best.

Antimicrobial Resistance Benchmark

The first report to compare what pharmaceutical companies are doing to bring antimicrobial resistance under control. By highlighting innovative actions, it encourages more companies to seize opportunities for change.

Access to Vaccines Index

Reports what vaccine companies are doing to ensure all children can be immunised wherever they live. By uncovering what is working and where, this Index helps ensure vaccine markets also reach the poorest and most remote communities.
Type search term(s) and press enter
Often searched for
Index Ranking Vacancies 10-year analysis R&D pipelines AMR antibiotics Investors

News

All the latest news about the Access to Medicine Foundation, our research programmes and engagement activities. 

All Access to Medicine Foundation Access to Medicine Index Antimicrobial Resistance Benchmark Access to Vaccines Index

14 Nov 2016

New online: 2016 Access to Medicine Index

The 2016 Access to Medicine Index, published Monday, ranks 20 of the world’s largest pharmaceutical companies on their efforts to improve access...

08 Nov 2016

Which pharmaceutical companies have the most essential medicines and vaccines?

The new analysis by the Access to Medicine Foundation shows which large pharmaceutical companies are marketing the most essential medicines and vaccin...

02 Nov 2016

UNICEF covers the upcoming Access to Vaccines Index

Margot de Graaff from the UNICEF Netherlands magazine interviews Jayasree K. Iyer and Suzanne Wolf regarding the pharmaceutical industry, the Access t...

24 Oct 2016

2016 Access to Medicine Index: out in November

The Access to Medicine Foundation is preparing a new iteration of its leading sustainability Index of pharmaceutical companies – the next Access to Me...

20 Sep 2016

AMR and Access to Cancer Medicine, discussing the role of the pharma industry

This week, Jayasree K. Iyer will participate in two key events on the role of the pharmaceutical industry regarding access to antimicrobials and antim...

24 Aug 2016

Jayasree K. Iyer to chair panel on barriers to NCDs in sub-Saharan Africa

On 26 August in Nairobi, African leaders and the Japanese government will come together to discuss trade, investment and development at teh sixth Toky...

01 Jul 2016

Now online: Going beyond CSR to reach ‘the two billion’ by Jayasree K. Iyer for PharmaPhorum

Many pharma companies have corporate social responsibility (CSR) departments, but some are going further and putting access to medicine at the core of...

10 Jun 2016

Access to Vaccines Index: the data is in, analysis can begin.

The Access to Vaccines Index will analyse how vaccine companies are improving access to high-priority vaccines for communities in need. The Foundation...

03 Jun 2016

Ongoing dialogue: with Japanese pharma industry and at OECD Responsible Business Forum

From June 6–9, Executive Director, Jayasree K. Iyer, will be in Tokyo to follow up on the Foundation’s recent dialogue with Japanese pharmaceutical co...

20 May 2016

The Access to Medicine Foundation at the 69th WHO World Health Assembly

The WHO’s annual World Health Assembly (WHA) draws the greatest minds working on global health. This year, Jayasree K. Iyer, Executive Director, toget...

26 Apr 2016

Data collection in progress for the 2016 Access to Medicine Index

The world’s top 20 pharmaceutical companies are now submitting data for the 2016 Access to Medicine Index, on the measures they are taking to improve...

09 Mar 2016

How the Access to Medicine Index inspires stronger action by pharma companies

An Independent Impact Evaluation concludes that the Access to Medicine Index is a catalyst and inspiration for pharma companies to do more for the two...

08 Jan 2016

Dialogue on Access to Medicine with Japanese pharma companies

From 12 to 15 January, the Access to Medicine Foundation will be visiting Tokyo, Japan for a series of meetings with Japan-based pharmaceutical compan...

06 Jan 2016

Suzanne Wolf talks about access to vaccines for children in RTL4's 'Koffietijd'

On the popular Dutch TV-show 'Koffietijd' (Coffeetime) presenter Pernille La Lau interviewed Suzanne Wolf, Director of Communications at the Access to...

01 Dec 2015

A new catalyst for change: methodology for the first Access to Vaccines Index

The Access to Medicine Foundation is introducing a new tool for action – the Access to Vaccines Index. It will analyse how vaccine companies are impro...

24 Nov 2015

The Bulletin of WHO publishes an article on the thematic study: hepatitis C by the Access to Medicine Foundation

The Bulletin of the World Health Organization has published the latest study from the Access to Medicine Foundation: on how the world’s largest pharma...

Learn more

View our detailed overview of each company’s performance in the Index, including breakdowns of their product portfolios and R&D pipelines.